Innovation fuels our service portfolio. Our platform pipeline is focused on translational science and improved clinical outcomes for people with cancer and CNS diseases. Developing tests for neuroinflammation and the tumor microenvironment are two key areas of research at Biotect Services. With our core services and expanding capabilities, we can boost characterization of your drug or biological product with indications for brain cancer, multiple sclerosis, Parkinson’s, ischemia, Alzheimer’s disease, and opioid addiction, to name a few.
